Corporate
Neutral
Clearmind Medicine Completes First Cohort Treatment in its FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder
Breaking news from global financial markets
il y a 1 semaine
Lire Plus
il y a 1 semaine
3,997
il y a 1 semaine
2,980
il y a 1 semaine
972
il y a 1 semaine
2,448
il y a 1 semaine
2,038
il y a 1 semaine
2,076
il y a 1 semaine
3,839
il y a 1 semaine
2,905
il y a 1 semaine
3,278
il y a 1 semaine
3,739
il y a 1 semaine
1,736
il y a 1 semaine
3,798
il y a 1 semaine
1,170
il y a 1 semaine
1,710
il y a 1 semaine
1,232
Tendances Actuelles
1
IO DeFi Launches New Mobile App, Making BTC and XRP Hashrate Earnings Accessible...
2,664
il y a 4 jours
2
BPCE : Mise à disposition du troisième amendement au document d’enregistrement u...
49,817
il y a 4 jours
3
AVTR Investors Have Opportunity to Lead Avantor, Inc. Securities Fraud Lawsuit w...
4,862
il y a 4 jours
4
BTCC November 2025 Product Update: Exchange Introduces Futures Pro Copy Trading
23,009
il y a 4 jours
5
Trex Company, Inc. (TREX) Faces Investor Scrutiny Amid Disappointing Q3, Revised...
21,946
il y a 4 jours